Michael P. Cruse
Equibles does not estimate personal net worth.
Get an email with a short summary when OnKure Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get OKUR alertsAbout Michael P. Cruse
Michael P. Cruse is recorded as COO at OnKure Therapeutics, Inc. (OKUR). The proxy statement of OnKure Therapeutics, Inc. reports total compensation of $781,474 for Michael P. Cruse in fiscal 2022, including a base salary of $391,474. Disclosed compensation is on record for 2 fiscal years. OnKure Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at OnKure Therapeutics, Inc. includes Nicholas A. Saccomano (CEO and Board Member), Nicholas A. Saccomano, Ph.D. (CEO), Nicholas Saccomano (CEO and Board Member) and 7 others.
Affiliation history
-
Current
Company network
Leadership on record at OnKure Therapeutics, Inc.
- Nicholas A. Saccomano CEO, Board Member
- Nicholas A. Saccomano, Ph.D. CEO
- Nicholas Saccomano CEO, Board Member
- Andrew Phillips Chairman, Board Member
- Jason Leverone CFO
- Jennifer P. Lam CFO
- Andrew Philips, Ph.D. Board Member
- Continuing Directors Board Member
- Dr. Liam Ratcliffe Board Member
- Edward T. Mathers Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | OnKure Therapeutics, Inc. (OKUR) | Chief Operating Officer | $391,474 | $781,474 |
| 2021 | OnKure Therapeutics, Inc. (OKUR) | Chief Operating Officer | $300,000 | $1,496,036 |
Recent activity
No call appearances or filed executive changes recorded yet.